SUMMARY
Following an application from Specialised Nutrition Europe (formerly IDACE), submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924 No /2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to selenium and protection of DNA, proteins and lipids from oxidative damage.
The scope of the application was proposed to fall under a health claim referring to children's development and health.
The food constituent that is the subject of the health claim is selenium, which is an essential nutrient and is measurable in foods by established methods. Selenium occurs naturally in foods and is authorised for addition to foods and for use in food supplements. The Panel considers that selenium is sufficiently characterised.
The claimed effect proposed by the applicant is "acts as an antioxidant to protect cells and tissues from oxidative damage". The target population proposed by the applicant is infants and young children from birth to three years of age. The Panel considers that the protection of body cells and molecules such as DNA, proteins and lipids from oxidative damage is a beneficial physiological effect.
The Panel has previously assessed a claim on selenium and protection of DNA, proteins and lipids from oxidative damage with a favourable outcome. The target population was the general population. The Panel considered that the role of selenium as an indirect component of the antioxidant network was well established.
The Panel considers that the role of selenium in the protection of DNA, proteins and lipids from oxidative damage applies to all ages, including infants and young children (from birth to three years of age). Dietary Reference Values for selenium have been set for infants and young children.
The Panel concludes that a cause and effect relationship has been established between the dietary intake of selenium and protection of DNA, proteins and lipids from oxidative damage.
The following wording reflects the scientific evidence: "Selenium contributes to the protection of DNA, proteins and lipids from oxidative damage".
In order to bear the claim, follow-on formulae should comply with the criteria of composition of follow-on formulae as laid down in Directive 2006/141/EC; nutritionally complete foods for special medical purposes intended for use by infants and nutritionally complete foods for special medical purposes other than those intended for use by infants should comply with the criteria of composition of these foods as laid down in Directive 1999/21/EC; processed cereal-based foods for infants and young children should comply with the criteria of composition of these foods as laid down in Directive 2006/125/EC; and other foodstuffs intended for infants and young children should provide at least 15 % of the reference values for nutrition labelling for foods intended for infants and young children as laid down in Directive 2006/141/EC. Such amounts can easily be consumed as part of a balanced diet. The target population is infants and children up to three years of age. 4 harmonises the provisions that relate to nutrition and health claims, and establishes rules governing the Community authorisation of health claims made on foods. As a rule, health claims are prohibited unless they comply with the general and specific requirements of this Regulation, are authorised in accordance with this Regulation, and are included in the lists of authorised claims provided for in Articles 13 and 14 thereof. In particular, Articles 14 to 17 of this Regulation lay down provisions for the authorisation and subsequent inclusion of reduction of disease risk claims and claims referring to children's development and health in a Community list of permitted claims.
According to Article 15 of this Regulation, an application for authorisation shall be submitted by the applicant to the national competent authority of a Member State, which will make the application and any supplementary information supplied by the applicant available to the European Food Safety Authority (EFSA).
STEPS TAKEN BY EFSA


The application was received on 14/02/2008.
The scope of the application was proposed to fall under a health claim referring to children's development and health. 
TERMS OF REFERENCE
EFSA is requested to evaluate the scientific data submitted by the applicant in accordance with Article 16 of Regulation (EC) No 1924 No /2006 . On the basis of that evaluation, EFSA will issue an opinion on the scientific substantiation of a health claim related to: selenium and protection of DNA, proteins and lipids from oxidative damage.
EFSA DISCLAIMER
The present opinion does not constitute, and cannot be construed as, an authorisation for the marketing of selenium, a positive assessment of its safety, nor a decision on whether selenium is, or is not, classified as a foodstuff. It should be noted that such an assessment is not foreseen in the framework of Regulation ( 
INFORMATION PROVIDED BY THE APPLICANT
Applicant's name and address: Specialised Nutrition Europe (formerly IDACE), 9-31 Avenue des Nerviens, 1040 Brussels, Belgium.
Food/constituent as stated by the applicant
According to the applicant, the food constituent for which the claim is made is selenium.
Health relationship as claimed by the applicant
According to the applicant, selenium acts as an antioxidant to protect cells and tissues from oxidative damage.
Wording of the health claim as proposed by the applicant
The applicant has proposed the following wording for the health claim: "Selenium has an antioxidant functionality that helps maintain and protect healthy cells".
As equivalent alternative wordings, the applicant has proposed: "Selenium contributes to/helps in/protects/supports/is necessary for/is needed for the maintenance of/protection of/function of/normal function of cells/anti-oxidative capacity". "Selenium is an anti-oxidant." "Selenium helps scavenging free radicals."
Specific conditions of use as proposed by the applicant
According to the applicant, the target population is infants and young children from birth to three years of age. The claim should be used on foods that are exclusively intended for the category of infants and young children, and in line with the composition laid down in the specific directives According to the applicant, the quantities needed to achieve the claimed effect are as follows: 
ASSESSMENT
Characterisation of the food/constituent
The food constituent that is the subject of the health claim is selenium, which is an essential nutrient and is measurable in foods by established methods.
Selenium occurs naturally in foods and is authorised for addition to foods and for use in food supplements (Annex I of Regulation ( The Panel considers that the food constituent, selenium, which is the subject of the health claim, is sufficiently characterised.
Relevance of the claimed effect to human health
The claimed effect proposed by the applicant is "acts as an antioxidant to protect cells and tissues from oxidative damage". The target population proposed by the applicant is infants and young children from birth to three years of age.
Reactive oxygen species (ROS), including several kinds of radicals, are generated in biochemical processes (e.g. respiratory chain) and as a consequence of exposure to exogenous factors (e.g. radiation, pollutants). These reactive intermediates damage biologically relevant molecules such as DNA, proteins and lipids if they are not intercepted by the antioxidant network, which includes free radical scavengers such as antioxidant nutrients.
The Panel considers that the protection of body cells and molecules such as DNA, proteins and lipids from oxidative damage is a beneficial physiological effect.
Scientific substantiation of the claimed effect
The Panel has previously assessed a claim on selenium and protection of DNA, proteins and lipids from oxidative damage with a favourable outcome (EFSA NDA Panel, 2010) . The target population was the general population.
The Panel considered that the role of selenium as an indirect component of the antioxidant network is well established (EFSA NDA Panel, 2010) . The antioxidant defence system comprises low molecular weight antioxidants and antioxidant enzymes, such as glutathione peroxidases, which catalyse the reduction of hydrogen peroxide or organic hydroperoxides using reduced glutathione as a co-substrate (Papp et al., 2007) . These enzymes and other selenoenzymes, such as the thioredoxin reductases, which are also involved in antioxidant defence, are selenium dependent and can respond to selenium supplementation (EFSA NDA Panel, 2010).
The Panel considers that the role of selenium in the protection of DNA, proteins and lipids from oxidative damage applies to all ages, including infants and young children (from birth to three years of age). Dietary Reference Values for selenium have been set for infants and young children (EFSA NDA Panel, 2014) .
Panel's comments on the proposed wording
The Panel considers that the following wording reflects the scientific evidence: "Selenium contributes to the protection of DNA, proteins and lipids from oxidative damage".
Conditions and restrictions of use
The Panel considers that, in order to bear the claim:
 follow-on formulae should comply with the criteria of composition of follow-on formulae as laid down in Such amounts can easily be consumed as part of a balanced diet. The target population is infants and children up to three years of age. Tolerable Upper Intake Levels (UL) have been established as 60 µg/day for children of 1-3 years (SCF, 2000) .
CONCLUSIONS
On the basis of the data presented, the Panel concludes that:
 The food constituent, selenium, which is the subject of the health claim, is sufficiently characterised.
 The claimed effect proposed by the applicant is "acts as an antioxidant to protect cells and tissues from oxidative damage". The target population proposed by the applicant is infants and young children from birth to three years of age. Protection of body cells and molecules such as DNA, proteins and lipids from oxidative damage is a beneficial physiological effect.
 A cause and effect relationship has been established between the dietary intake of selenium and protection of DNA, proteins and lipids from oxidative damage. 
